PPB Takes Firm Action to Combat Illegal Practices in the Pharmaceutical Industry
Nairobi, Kenya – June 9, 2023 – In a resolute move to combat the presence of illegal practices in the pharmaceutical industry, the Pharmacy and Poisons Board (PPB) of Kenya has taken proactive measures to protect public health and uphold industry standards. During the 19th Annual Scientific Conference of the Kenya Pharmaceutical Association, Central Branch, Dr. Charles Githinji, Chairman of the PPB, unveiled a comprehensive plan to address this pressing issue.
The PPB’s strategy focuses on implementing identifiers for registered premises, geospatial mapping, and a multi-agency approach to enhance regulatory oversight. “These measures are aimed at cracking down on illegal practices and ensuring strict adherence to regulations within the pharmaceutical industry,” the chairman said.
Dr. Githinji’s presentation at the conference also highlighted the significant progress being made by the PPB in reaching the World Health Organization’s Global Benchmarking Tool (GBT) Maturity Level 3. This remarkable move showcases the board’s unwavering commitment to aligning its practices and regulatory framework with international standards, ultimately ensuring the highest level of quality and safety in the pharmaceutical sector.
By implementing identifiers for registered premises, the PPB will be able to effectively track and monitor authorized pharmaceutical outlets, minimizing the risk of unlicensed establishments operating illegally. He said, the Geospatial mapping will provide valuable data to identify and address areas where illegal practices are prevalent, enabling targeted interventions and focused regulatory actions.
Furthermore, the PPB’s multi-agency approach involves collaborating with various government agencies and stakeholders, fostering a collective effort to eradicate illegal practices. “By working together, these entities can strengthen enforcement efforts and ensure that offenders are swiftly brought to justice,” he stated.
The PPB’s commitment to achieving the World Health Organization’s Global Benchmarking Tool (GBT) Maturity Level 3 signifies its dedication to international best practices. This milestone demonstrates the board’s commitment to continuously improving its regulatory framework, aligning with global standards, and safeguarding public health.
Through these initiatives, the PPB aims to create an environment where legal pharmaceutical practices thrive, ensuring that Kenyan citizens have access to safe, efficacious, and quality medicines. “By enforcing regulations, implementing innovative strategies, and collaborating with stakeholders, the PPB is committed to making significant strides in protecting public health and upholding industry standards,” he noted.
